stockrow
Friday 6 November 2026
Export CCLD’s income statement to Excel — free account
CareCloud, Inc.
CCLD Healthcare Health Information Services
CareCloud, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $120.5 million, up 8.72% from fiscal 2024.
- Revenue
- +8.56%
- EPS
- +150.0%
- Free cash flow
- −0.44%
- Total debt
- +44,345.3%
Quarter to September 2026, against a year earlier
2.31
0.15
+6.94%
Follow CCLD
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
15.69 | 30.29 | 33.18 | 36.50 |
+8 more quarters Free account |
P/S ratio |
0.66 | 0.70 | 1.25 | 0.92 | |
P/FCF ratio |
4.85 | 4.60 | 8.04 | 5.37 | |
P/Operating CF |
15.37 | 12.74 | 42.93 | 12.72 | |
P/B ratio |
3.83 | 5.18 | 2.66 | 1.85 | |
Price to Tangible BV |
0.00 | 0.00 | 14.92 | 12.13 | |
EV/Sales |
0.93 | 0.91 | 1.24 | 0.91 | |
EV/EBITDA |
4.82 | 4.60 | 5.85 | 4.11 | |
EV/Operating CF |
4.89 | 4.37 | 5.67 | 3.82 | |
EV/FCF |
6.84 | 5.96 | 7.96 | 5.32 | |
Quick Ratio |
0.65 | 0.82 | 0.81 | 0.76 | |
Current Ratio |
0.87 | 1.02 | 1.11 | 1.05 | |
Net Debt/EBITDA |
0.00 | 4.41 | (0.71) | (0.52) | |
Debt/Assets |
0.00% | 40.73% | 0.29% | 0.50% | |
Debt/Equity |
0.00 | 2.20 | 0.00 | 0.01 | |
Asset Turnover |
1.48 | 1.52 | 1.55 | 1.51 | |
Operating CF/Net income |
1.35 | 39.08 | (8.15) | 5.70 | |
Capex/Depreciation |
— | (0.35) | (0.30) | (0.97) | |
Interest Coverage |
3.65 | 2.28 | 17.24 | 222.71 | |
Research and Development Expense of Revenue |
3.12% | 6.88% | 7.73% | 7.39% | |
Selling, General and Administrative Expense of Revenue |
18.55% | 20.92% | 22.10% | 18.17% | |
Intangible Assets out of Total Assets |
0.53 | 0.50 | 0.55 | 0.58 | |
Share Based Compensation of Revenue |
0.19% | 0.20% | 0.20% | 0.43% | |
Graham Net Nets |
(0.42) | (0.47) | (0.01) | (0.02) | |
Graham Number |
1.25 | 0.80 | 1.84 | 1.68 | |
Earnings Yield |
6.37% | 3.30% | 3.01% | 2.74% | |
Free Cash Flow Yield |
20.61% | 21.76% | 12.43% | 18.61% | |
Revenue per Share |
0.79 | 0.75 | 0.74 | 0.91 | |
Operating CF per Share |
0.13 | 0.17 | 0.09 | 0.23 | |
Capex per Share |
0.00 | (0.03) | (0.03) | (0.08) | |
Free Cash Flow per Share |
0.13 | 0.14 | 0.06 | 0.15 | |
Cash per Share |
0.11 | 0.32 | 0.09 | 0.10 | |
Shareholders Equity per Share |
0.53 | 0.41 | 1.37 | 1.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.53 | 0.41 | 1.37 | 1.57 | |
Free Cash Flow |
5.64 | 5.75 | 2.38 | 5.81 | |
Working Capital |
(4.24) | 0.70 | 2.63 | 1.32 | |
Capital Expenditures |
— | (1.32) | (1.23) | (2.87) | |
Net Current Asset Value |
(36.08) | (42.26) | (2.30) | (2.35) | |
EV/EBIT |
9.74 | 12.72 | 14.86 | 9.63 | |
Capex to Sales |
0.00 | 0.04 | 0.04 | 0.08 | |
Price to Operating Income |
6.91 | 9.80 | 15.02 | 9.73 | |
| Other line items | |||||
Average Receivables |
15.92 | 13.84 | 14.56 | 13.92 | |
Average Payables |
6.45 | 5.14 | 5.23 | 5.75 | |
Average Inventory |
0.56 | 0.50 | 0.52 | 0.54 | |
Average Assets |
88.84 | 84.55 | 80.14 | 79.61 | |
Average Common Equity |
40.21 | 36.74 | 56.25 | 54.64 |
Columns are period end dates · fundamentals updated 5 Nov 2026